The Indian pharmaceutical market (IPM) registered a 6.1 per cent value growth in October 2024, with major therapies showing ...

Cipla’s FDA-compliant facilities and its investments in US-based units place it in a strong position to weather potential ...

Dr Reddy's Laboratories is aiming to move up to the fifth rank in the Indian pharma market within the next five years, the ...

Market Regulator Securities and Exchange Board of India (SEBI) has cleared Piramal Pharma Ltd (PPL) of allegations concerning ...

Revenue for Emcure Pharma Q2 rose by over 20%, totaling ₹2,002 Crore, driven by strong performance across segments.

New Delhi based NGO Udyog Development Foundation (UDF) has called for an experts meeting themed “India Pharmacists' Adhiveshan” towards creation of regulatory service cadre in the pharma sector for ...

Alembic Pharmaceuticals stated that it gained final FDA approval for the Diltiazem Hydrochloride Extended-Release capsules, ...

India needs to expand its local vaccine manufacturing and research to give better control over safety of these pharma ...

Stay updated with the Sun Pharma Stock Liveblog, your one-stop destination for real-time information and analysis of a ...

The pharmaceutical industry is poised for an opportunity to tweak parts of the Medicare drug pricing negotiation law, after ...

Alembic Pharmaceuticals, established in 1907, operates state-of-the-art research and manufacturing facilities approved by ...

Next week’s notable names in Q2 results include Apollo Tyres, Bayer CorpScience, Hyundai Motor India, 3M India, Ramco Cements ...